LIVE

WST

West Pharmaceutical Services, Inc.

WST

NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $25.8B

$365.74

+0.20%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$206.80 - $367.57

P/E

48.83

Fwd P/E

46.83

Beta

1.18

Div Yield

0.24%

Avg Vol

855.4K

Shares Out

70.6M

Mkt Cap

$25.8B

Price action

Price chart

Up 65.0% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary polymer and packaging technologies
  • Global manufacturing and distribution network
  • Deep regulatory compliance expertise
  • Long-standing pharmaceutical industry relationships

Bear Case

2 risks

  • Average volatility.
  • High premium - requires strong execution

Growth

Stable outlook

Increasing global biologics market

Value

High premium - requires strong execution

Momentum

Hot

+43.3% over 3m

Quality

Stable

Exceptional business - top-tier fundamentals

Dividend

Token

0.24% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 22, 2026

Q2 26 RECAP

APR 23, 2026

Reported EPS of $2.13 vs $1.68 consensus (+26.8% surprise). Revenue of $844.9M vs $780.3M expected (+8.3%). Beat on both top and bottom lines.

EPS beat +26.8%
Rev beat +8.3%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+26.8%

Next: Apr 22, 2026

Revenue trend · last 8Q

+2%

+0%

+9%

+8%

+8%

+21%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$702.0M

$746.9M

$748.5M

$698.2M

$766.2M

$804.3M

$805.0M

$844.9M

Margins · last 8Q

Gross

35.1%

Operating

21.0%

Profit

16.4%

Wall Street consensus

4 analysts · 75% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

75%

Hold

1

25%

Sell

0%

Median Price Target

$312.50

-14.6% vs $365.74

Low $310.00
Median $312.50
High $315.00

Latest: KeyBanc · Jul 2, 2026

2 analysts covering

vs Industry

How WST stacks vs Medical - Instruments & Supplies

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.